NPC at a Glance
NPC is a health policy research organization focused on the critical issues of evidence, the value of medicines for patients, and innovation...more
CER
Do stakeholders think comparative effectiveness research is having an impact on health care decision making? Which organizations are viewed as the leaders on prioritizing, funding, and conducting research? Download our new booklet to find out...more
Value of Rx
Recent NPC research has focused on defining the optimal role and value of pharmaceuticals in the evolving payment and delivery models...more
Individual Treatment Effects
Being "unique" can impact your health care treatments. Learn more about the challenges of individual treatment effects...more
RECENT NEWS
Health Affairs Article Highlights Benefit of Reducing Low-Value Health Care
(Washington, D.C., September 20, 2016) – A post published today on the Health Affairs Blog brings to light the... more
Optimizing the recipe for ‘health care spending pie’: Finding the most effective resource allocation
As health care costs continue to climb, rising 5.3 percent in 2015 and approaching 18 percent of the U.S.... moreNational Pharmaceutical Council to Host Conference on Measuring Health Care Value and Impact on Patient Care
(Washington, DC, September 15, 2016)—The National Pharmaceutical Council (NPC) will bring together health care... moreExploring “Dynamic” Cost-sharing Models in Value-based Insurance Design
Consider this scenario: You have a chronic condition and, thankfully, there are three medications that could... more
PCORI Announces $153 Million in Funding for 35 New Projects
During the July 19 Patient-Centered Outcomes Research Institute (PCORI) Board of Governors meeting, the Board... moreDeveloping and Using Value Frameworks
With the increase in the use of innovative specialty biopharmaceuticals and targeted therapies to treat broader... moreWhat’s the Fuss About Evidence From Clinical Experience? Here’s Why It Matters
At a health care forum in Washington, DC, earlier this month, panelists raised concerns about the ability of the... morePCORI Hosts Annual Meeting & Promotes Survey
The Patient-Centered Outcomes Research Institute (PCORI) hosted its first annual meeting, “Progress in Building... moreHealth Affairs Article Highlights Benefit of Reducing Low-Value Health Care
(Washington, D.C., September 20, 2016) – A post published today on the Health Affairs Blog brings to light the... moreNational Pharmaceutical Council to Host Conference on Measuring Health Care Value and Impact on Patient Care
(Washington, DC, September 15, 2016)—The National Pharmaceutical Council (NPC) will bring together health care... moreNational Pharmaceutical Council Remains Engaged With the Institute for Clinical and Economic Review, Continuing Constructive Dialogue to Improve Value Assessment Frameworks
(Washington, DC, September 8, 2016)—The National Pharmaceutical Council (NPC) Board of Directors has agreed to... moreNPC Takes Issue With ICER's Mischaracterization of Funding Sources
The National Pharmaceutical Council (NPC) takes exception to the Institute for Clinical and Economic Review’s (... more
NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Framework
September 12, 2016Steven D. Pearson, MD, MSc, FRCP President Institute for Clinical and Economic Review One... moreThinking Differently About How We Assess Health Value
Health care stakeholders remain divided over how the value of health care treatments—especially medicines—should... moreNPC Comments on Revised PCORI Methodology Standards
March 28, 2016Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite... moreNPC Comments on AMCP Format for Formulary Submission Version 4.0
Attn: Dr. Susan Oh, PharmD, Assistant Director of Pharmacy Affairs, Academy of Managed Care PharmacyThe... more
2016 Comparative Effectiveness Research and the Environment for Health Care Decision-Making
This one-hour webinar highlights the results of NPC's annual survey of comparative effectiveness research (CER)... moreWebinar: Risk-Sharing Agreements in the U.S.: Trends, Barriers & Prospects
Kimberly Westrich, MA, vice president, health services research, National Pharmaceutical Council (NPC),... moreWhen Is Evidence Fit for Purpose? Closing Gaps Between Researchers, Payers
Despite multi-million dollar public and private investments to tap into big data and improve the evidence... moreAnthem's Dr. Malin on Clinical Care Pathways and Innovation
Could clinical care pathways help innovation? Anthem Inc.'s Dr. Jennifer Malin, medical director, oncology and... moreOptimizing the recipe for ‘health care spending pie’: Finding the most effective resource allocation
As health care costs continue to climb, rising 5.3 percent in 2015 and approaching 18 percent of the U.S.... moreExploring “Dynamic” Cost-sharing Models in Value-based Insurance Design
Consider this scenario: You have a chronic condition and, thankfully, there are three medications that could... moreNPC Submits Comments to Institute for Clinical and Economic Review on Its Value Assessment Framework
The National Pharmaceutical Council (NPC) today submitted comments to the Institute for Clinical and Economic... more